Biostax Corp.
IMUNDelisted Feb 20, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001559356
Biostax Corp. was delisted on Feb 20, 2025; its insiders filed their last Form 4 on Feb 22, 2023; no institution reported holding it in 13F filings for Q2 2023; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Biostax Corp. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Biostax Corp., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Farmer Glen A | Chief Financial Officer | 409,000 | Feb 22, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 22, 2023 (view filing)7:00 PM ET | Feb 10 | 12 daysLate | Farmer Glen AChief Financial Officer | PPurchase | +409.0K | $0.045 | +$18.4K | New position409.0K after |